Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

GNOM ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

GNOM Analyst Ratings

Moderate Buy
50ConsensusRatings
42Buy8Hold0Sell
Based on the Wall Street analyst consensus for 50 of GNOM’s holdings.

GNOM 12 Month Forecast

$81.61▲(24.45% Upside)
Based on Wall Street analyst 12-month price targets for 50 of Global X Genomics & Biotechnology ETF’s holdings in the last 3 months. The average price target is $81.61 with a high forecast of $112.47 and a low forecast of $51.76. The average price target represents a 24.45% change from the last price of $65.58.
Highest Price Target$112.47Average Price Target$81.61Lowest Price Target$51.76

GNOM Stocks With Highest Upside Potential

GNOM highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Buy$3.75(604.89% Upside)
Strong Buy$18.74(489.33% Upside)
Moderate Buy$9.50(314.85% Upside)
Strong Buy$21.73(225.26% Upside)
Strong Buy$702.18(177.58% Upside)

GNOM Stocks With Highest Downside Potential

GNOM highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$123.75(-38.16% Downside)
Hold$3.83(-34.22% Downside)
Moderate Buy$57.00(-17.64% Downside)
Moderate Buy$249.13(-7.53% Downside)
Hold$19.00(-5.47% Downside)

GNOM ETF FAQ

What is GNOM’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 50 of GNOM’s holdings, Global X Genomics & Biotechnology ETF’s 12-month average price target is $81.61.
What is GNOM’s upside potential, based on the analysts’ average price target?
GNOM’s average price target of $81.61 represents a 24.45% upside from its last price of $65.58.
Is GNOM a Buy, Sell or Hold?
Global X Genomics & Biotechnology ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 50 of GNOM’s holdings: 42 rated Buy, 8 rated Hold and 0 rated Sell.
What is Global X Genomics & Biotechnology ETF’s price target?
The average price target for Global X Genomics & Biotechnology ETF is $81.61, based on Wall Street analyst 12-month price targets for 50 of GNOM’s holdings, issued in the past 3 months. The highest price target is $112.47 and the lowest is $51.76. The average price target represents a 24.45% increase from the last price of $65.58.
What is GNOM’s expense ratio?
GNOM’s expense ratio is 0.50%.
How many holdings does GNOM have?
GNOM holds 51 assets.
How can I buy shares of GNOM?
You can buy shares of GNOM through a brokerage account. Compare brokers on our Best Online Brokers page.